MS Pharma acquired Athens-based Genepharm in 2019.

With solid local relationships and a team of experienced employees in Greece, the business extends to over 85 countries globally via strategic alliances, based on developing new products and continuous investment in infrastructure and technologies.

The company has three dedicated production facilities, designed per EU cGMP requirements, sells its products through wholesalers in the Greek market, and has a dedicated sales and marketing team responsible for delivering scientific messages to doctors and pharmacists. Branded Genepharm products are also sold through distributors in selected markets.